1-4 of 4
Sara Samiee
Close
Sort by
Journal Articles

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma: Improved Outcomes in Patients with Longer Disease Free Interval after First ASCT.

Joseph R. Mikhael, MD, Sahar Zadeh, BSc, Sara Samiee, MD, Keith Stewart, MD, Christine Chen, MD, Suzanne Trudel, MD, Vishal Kukreti, MD, Norman Franke, MD, Andrew Winter, BScN, Drew Phillips, Donna Reece, MD
Journal: Blood
Blood (2007) 110 (11): 946.
https://doi.org/10.1182/blood.V110.11.946.946
Published: 2007
Journal Articles

Prognostic Relevance of CD56 Expression in Patients with Multiple Myeloma Treated with High-Dose Melphalan-Based Chemotherapy and Autologous Stem Cell Transplant.

Joanna Yeung, Sara Samiee, Qi Long Yi, Dominic Pantalony, Hong Chang
Journal: Blood
Blood (2005) 106 (11): 5086.
https://doi.org/10.1182/blood.V106.11.5086.5086
Published: 2005
Journal Articles

t(11;14) Is Infrequent in Long-Term Myeloma Survivors.

Hong Chang, Sara Samiee, Xiao Ying Qi, Qi Long Yi, A. Keith Stewart
Journal: Blood
Blood (2004) 104 (11): 4890.
https://doi.org/10.1182/blood.V104.11.4890.4890
Published: 2004
Journal Articles

Outcome after Second Autologous Stem Cell Transplantation as Salvage Therapy in Patients with Relapsed Multiple Myeloma.

Joseph R. Mikhael, MD, Sara Samiee, MD, A. Keith Stewart, MD, Christine Chen, MD, Suzanne Trudel, MD, Norman Franke, MD, Andrew Winter, BScN, Hong Chang, MD, PhD, Donna E. Reece, MD
Journal: Blood
Blood (2004) 104 (11): 943.
https://doi.org/10.1182/blood.V104.11.943.943
Published: 2004